Author:Bagnato, Francesca Sati, Pascal Hemond, Christopher Elliott, Colm Gauthier, Susan Harrison, Daniel Mainero, Caterina Oh, Jiwon Pitt, David Shinohara, Russell Smith, Seth Bruce, Trapp Azevedo, Christina Calabresi, Peter Henry, Roland Laule, Cornelia Ontaneda, Daniel Rooney, William Sicotte, Nancy Reich, Daniel Absinta, Martina
Session Name:P11: MS Neuroimaging 2
Topic:MS and Inflammatory Disease
Program Number:P11.009
Author Institution:Vanderbilt University Medical Center, Nashville, TN Cedars-Sinai Medical Center, Los Angeles, CA University of Massachusetts Memorial Medical Center, Worcester, MA NeuroRx Research, Montreal, QC, Canada Weill Cornell Medicine, New York, NY University of Maryland School of Medicine, Baltimore, MD Massachusettes General Hosptial, Charlestown, MA St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada Yale School of Medicine, New Haven, CT University of Pennsylvania, Philadelphia, PA Vanderbilt University Institute of Imaging Science, Nashville, TN Cleveland Clinic, Cleveland, OH University of Southern California, Los Angeles, CA Johns Hopkins University, Baltimore, MD University of California, San Francisco, San Francisco, CA University of British Columbia, Vancouver, BC, Canada Oregon Health & Science University, Portland, OR National Institutes of Health, Neuroimmunology Branch, NINDS, Bethesda, MD St. Raffaele Hospital, Milan, Italy
Author:Jameie, Melika Togha, Mansoureh Azizmohammad Looha, Mehdi Hemmati, Nima Jafari, Elham Nasergivehchi, Somayeh Ghorbani, Zeinab Salami, Zhale
Session Name:P14: Headache: Epidemiology and Population Health 2
Topic:Headache
Program Number:P14.003
Author Institution:Iranian Center of Neurological Research, Neuroscience Institute, Tehran Universoty of Medical Sciences, Tehran, Iran, Tehran, Iran Iranian Center of Neurological Research, Neuroscience Institute, Tehran Universoty of Medical Sciences, Tehran, Iran, Tehran , Iran Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Tehran, Iran Iran University of Medical Sciences, Tehran, Iran, Tehran, Iran Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, Rasht, Iran
Author:Cohen, Jeffrey Hauser, Stephen Zielman, Ronald Das Gupta, Ayan Azmon, Amin Xi, Jing Mavrikis Cox, Gina Robertson, Derrick Wiendl, Heinz Kappos, Ludwig
Session Name:S16: MS Clinical Trials and Therapeutics
Topic:MS and Inflammatory Disease
Program Number:S16.009
Author Institution:Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH UCSF Weill Institute for Neurosciences, Department of Neurology, University of California - San Francisco, San Francisco, CA, USA, San Francisco, CA Central Texas Neurology Consultants, Round Rock, TX, USA, Round Rock, TX Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharma A.G., Basel, Switzerland, Basel, Switzerland China Novartis Institutes for BioMedical Research Co., Ltd, Shanghai, China, Shanghai, China, People's Republic of Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, USA, Tampa, FL University of Muenster, Muenster, Germany, Muenster, Germany Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Benedict, Ralph Penner, Iris Katharina Cutter, Gary Kappos, Ludwig Coyle, Patricia Piani-Meier, Daniela Azmon, Amin Boer, Ibolya Su, Wendy Cohen, Jeffrey
Session Name:P6: MS Clinical Trials
Topic:MS and Inflammatory Disease
Program Number:P6.005
Author Institution:Department of Neurology, University At Buffalo, Buffalo, NY Medical Faculty, Department of Neurology, Heinrich Heine University, COGITO Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany UAB School of Public Health, Birmingham, AL Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland Department of Neurology, SUNY At Stony Brook, Stony Brook, NY Novartis Pharma AG, Basel, Switzerland Novartis Pharmaceuticals Corporation, East Hanover, NJ Department of Neurology, Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH
Author:Wiendl, Heinz Cohen, Jeffrey Gold, Ralf De Seze, Jerome Robertson, Derrick Wray, Sibyl Sacca, Francesco Zielman, Ronald Azmon, Amin King, Miriam Fantaccini, Simone Kappos, Ludwig
Session Name:P6: MS Clinical Trials
Topic:MS and Inflammatory Disease
Program Number:P6.016
Author Institution:University of Muenster, Muenster, Germany Department of Neurology, Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany University Hospital of Strasbourg, Strasbourg, France Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL Hope Neurology MS Center, Knoxville, TN Department (NSRO), University “Federico II” of Naples, Naples, Italy Novartis Pharma B.V., Amsterdam, Netherlands Novartis Pharma AG, Basel, Switzerland Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland